Patient Demographics by Cancer Screening
Characteristics n (%) | Not Screened (n = 638) | Screened (n = 2,805) | Overall (n = 3,443) | P-valuea |
---|---|---|---|---|
Age | ||||
50 to 64 | 474 (74.3) | 1,624 (57.9) | 2,098 (60.9) | <0.001 |
65 to 74 | 164 (25.7) | 1,181 (42.1) | 1,345 (39.1) | |
Gender | ||||
Woman | 370 (58.0) | 1,603 (57.1) | 1,973 (57.3) | 0.927 |
Man | 268 (42.0) | 1,202 (42.9) | 1,470 (42.7) | |
Insurance type | ||||
Commercialb | 395 (61.9) | 1,478 (52.7) | 1,873 (54.4) | <0.001 |
Individual | 80 (12.5) | 2,16 (7.7) | 296 (8.6) | |
Medicare | 139 (21.8) | 1,030 (36.7) | 1,169 (34.0) | |
Medicaid/Dual | 24 (3.8) | 81 (2.9) | 105 (3.0) | |
Primary spoken language | ||||
English | 489 (76.6) | 2,365 (84.3) | 2,854 (82.9) | <0.001 |
Non-English | 30 (4.7) | 142 (5.1) | 172 (5.0) | |
Missing/Unknown | 119 (18.7) | 298 (10.6) | 417 (12.1) | |
Race | ||||
White | 424 (66.5) | 1,738 (62) | 2,162 (62.8) | 0.366 |
Otherb | 28 (4.4) | 91 (3.2) | 119 (3.5) | |
African American | 65 (10.2) | 332 (11.8) | 397 (11.5) | |
Asian | 59 (9.2) | 326 (11.6) | 385 (11.2) | |
Hispanic | 62 (9.7) | 318 (11.3) | 380 (11.0) | |
Neighborhood deprivation index | ||||
1 (Least Deprivation) | 85 (13.3) | 418 (14.9) | 503 (14.6) | 0.853 |
2 | 126 (19.7) | 612 (21.8) | 738 (21.5) | |
3 | 164 (25.7) | 647 (23.1) | 811 (23.6) | |
4 | 152 (23.8) | 679 (24.2) | 831 (24.2) | |
5 (Most Deprivation) | 110 (17.2) | 447 (15.9) | 557 (16.2) | |
Diagnostic cost groupc | ||||
Very Low <0.25 | 109 (17.1) | 173 (6.2) | 282 (8.2) | <0.001 |
Low 0.25-0.7 | 136 (21.3) | 434 (15.5) | 570 (16.6) | |
Moderate 0.7-0.1.3 | 131 (20.5) | 616 (22) | 747 (21.7) | |
High 1.3-3 | 120 (18.8) | 816 (29.1) | 936 (27.2) | |
Very High >3 | 142 (22.3) | 766 (27.3) | 908 (26.4) |
Missing: Insurance type n = 62 (1.8%), Primary spoken language n = 417 (12%), Race n = 8 (0.2%), Neighborhood deprivation index n = 3 (0.09%).
↵aBoldface indicates statistical significance (P < .05) [χ2 test comparing screened to not screened].
↵bInsurance Type Commercial and Race Other categories include missing values.
↵cDiagnostic Cost Group is a measure of how much a patient is expected to cost a healthcare system; it is used as a proxy for disease burden, with lower levels indicating healthier individuals.